Literature DB >> 2983429

Expression in Escherichia coli of open reading frame gene segments of HTLV-III.

N T Chang, P K Chanda, A D Barone, S McKinney, D P Rhodes, S H Tam, C W Shearman, J Huang, T W Chang, R C Gallo.   

Abstract

Human T-cell lymphotropic virus type III (HTLV-III), the causative agent of the acquired immune deficiency syndrome (AIDS), was recently isolated and its genomic structure analyzed by DNA cloning methods. In the studies reported here a combined cloning and expression system was used to identify HTLV-III encoded peptides that react immunologically with antibodies in sera from AIDS patients. Cloned HTLV-III DNA was sheared into approximately 500-base-pair fragments and inserted into an "open reading frame" expression vector, pMR100. The inserted DNA was expressed in Escherichia coli transformants as a polypeptide fused to the lambda CI protein at its amino terminus and to beta-galactosidase at its carboxyl terminus. Sera from AIDS patients containing antibodies to HTLV-III were then used to screen for immunoreactive fusion proteins. Twenty clones, each specifying a fusion protein strongly reactive with AIDS serum, were identified. DNA sequence analysis indicated that the HTLV-III fragments were derived from the open reading frame DNA segments corresponding to the gag and pol gene coding regions and also the large open reading frame region (env-lor) located near the 3' end of the viral genome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983429     DOI: 10.1126/science.2983429

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2.

Authors:  L Gonzalez; R W Boyle; M Zhang; J Castillo; S Whittier; P Della-Latta; L M Clarke; J R George; X Fang; J G Wang; B Hosein; C Y Wang
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.

Authors:  J J Wang; S Steel; R Wisniewolski; C Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2.

Authors:  W E Reiher; J E Blalock; T K Brunck
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays.

Authors:  S Ellinger; R Glockshuber; G Jahn; A Plückthun
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.

Authors:  R M Thorn; G A Beltz; C H Hung; B F Fallis; S Winkle; K L Cheng; D J Marciani
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

6.  Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections.

Authors:  J M Hofbauer; T F Schulz; P Hengster; C Larcher; R Zangerle; H Kofler; P Fritsch; H Wachter; M P Dierich
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.